![Andrew Robbins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Robbins
Amministratore Delegato presso COGENT BIOSCIENCES, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Andrew Robbins
Società | Posizione | Inizio | Fine |
---|---|---|---|
TURMERIC ACQUISITION CORP. | Direttore/Membro del Consiglio | 01/10/2020 | - |
Independent Dir/Board Member | 01/10/2020 | - | |
COGENT BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 23/10/2020 | - |
Amministratore Delegato | 23/10/2020 | - | |
Presidente | 23/10/2020 | - |
Storia della carriera di Andrew Robbins
Precedenti posizioni note di Andrew Robbins
Società | Posizione | Inizio | Fine |
---|---|---|---|
HARPOON THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/03/2020 | 11/03/2024 |
Independent Dir/Board Member | 28/03/2020 | 11/03/2024 | |
ARRAY TECHNOLOGIES, INC. | Direttore operativo | 02/03/2015 | 01/01/2019 |
Corporate Officer/Principal | 27/07/2012 | 02/03/2015 | |
PFIZER, INC. | Direttore operativo | 01/07/2012 | 01/03/2015 |
HOSPIRA, INC. | Corporate Officer/Principal | 01/01/2007 | 01/07/2012 |
StemCor Systems, Inc.
![]() StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Direttore/Membro del Consiglio | - | - |
Cytograft Tissue Engineering, Inc.
![]() Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Cytograft Tissue Engineering, Inc. engages in the development of cardiovascular medicine. It offers novel cell-based therapies to repair and rebuild diseased tissues and organ without using synthetic biomaterials. The company was founded by Todd N. McAllister and Nicolas L'Heureux in 2000 and is headquartered in Novato, CA. | Direttore/Membro del Consiglio | - | - |
FATE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - | - |
Formazione di Andrew Robbins
Swarthmore College | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Posizioni
Director/Board Member | 6 |
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 9 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
COGENT BIOSCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 6 |
---|---|
Array BioPharma, Inc.
![]() Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Hospira, Inc.
![]() Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Cytograft Tissue Engineering, Inc.
![]() Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Cytograft Tissue Engineering, Inc. engages in the development of cardiovascular medicine. It offers novel cell-based therapies to repair and rebuild diseased tissues and organ without using synthetic biomaterials. The company was founded by Todd N. McAllister and Nicolas L'Heureux in 2000 and is headquartered in Novato, CA. | Health Technology |
StemCor Systems, Inc.
![]() StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Health Technology |
Harpoon Therapeutics, Inc.
![]() Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Turmeric Acquisition Corp.
![]() Turmeric Acquisition Corp. Financial ConglomeratesFinance Turmeric Acquisition Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 28, 2020 and is headquartered in Cambridge, MA. | Finance |
- Borsa valori
- Insiders
- Andrew Robbins
- Esperienza